Cargando…

Анализ содержания мелатонина и его взаимосвязь с дисфункцией яичников у пациенток репродуктивного возраста с ожирением (обзор литературы)

One of the new directions in the study of reproductive disorders in obese women is the effect and receptor sensitivity of  melatonin on the gonadotropic function of the pituitary gland and ovariogenesis, taking into account the chronology of «light pollution». At the present stage, there is very lit...

Descripción completa

Detalles Bibliográficos
Autores principales: Михеев, Р. К., Андреева, Е. Н., Шереметьева, Е. В., Абсатарова, Ю. С., Пономарева, Т. А., Григорян, О. Р.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Endocrinology Research Centre 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8926146/
https://www.ncbi.nlm.nih.gov/pubmed/33586394
http://dx.doi.org/10.14341/probl12710
Descripción
Sumario:One of the new directions in the study of reproductive disorders in obese women is the effect and receptor sensitivity of  melatonin on the gonadotropic function of the pituitary gland and ovariogenesis, taking into account the chronology of «light pollution». At the present stage, there is very little literature on the influence of the aspects of «light pollution» on the problem of obesity and reproductive disorders in the literature. This review is an attempt to combine the above problem in terms of the impact of «light pollution» and the level of receptor sensitivity of melatonin in women of reproductive age with obesity. The literature search was carried out in Russian (eLibrary, CyberLeninka.ru) and international (PubMed, Cochrane Library) databases in Russian and English. Free access to the full text of the articles was a priority. The selection of sources was prioritized for the period from 2015 to 2019. However, given the insufficient knowledge of the chosen topic, the choice of sources was dated from 1992. The work was carried out as part of the study «Central and peripheral pathophysiological mechanisms of development of adipose tissue diseases, taking into account clinical and hormonal characteristics» 2020–2022.